Penelope Lane Elected to the Board as Managing Director

12 June 2024 – Melbourne, Australia – MLS Bio is pleased to announce that Ms Penelope Lane, Chief Executive Officer, has been formally elected to the company’s Board as Managing Director.

As CEO of MLS Bio, Penelope has already steered the company through its formative stages, assembling a highly experienced executive team, strengthening investor confidence, and advancing a pipeline of small-molecule therapeutics in oncology and infectious disease. Under her leadership, the company’s R&D strategy is tightly aligned with clinical translation, commercial viability, and patient impact.

With more than 20 years of international leadership across biotechnology, MedTech, healthcare, and public health, Penelope has played a pivotal role in shaping MLS Bio’s strategic direction, and establishing disciplined commercial execution.

Her appointment as Managing Director strengthens the alignment between the company’s governance and executive leadership, ensuring continuity as MLS Bio progresses toward clinical translation and international growth.